Design of Clofazimine-Loaded Lipid Nanoparticles Using Smart Pharmaceutical Technology Approaches
<b>Background/Objectives</b>: Clofazimine (CFZ) is a versatile antimicrobial active against several bacterial species, although its reduced aqueous solubility and the occurrence of side effects limit its use. Nanostructured lipid carriers (NLCs) constitute an interesting approach to incr...
Saved in:
| Main Authors: | Helena Rouco, Nicola Filippo Virzì, Carolina Menéndez-Rodríguez, Carmen Potel, Patricia Diaz-Rodriguez, Mariana Landin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/7/873 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycobactin and clofazimine activity are negatively correlated in mycobacteria
by: Martin I. Voskuil, et al.
Published: (2025-04-01) -
Clofazimine: History and Perspectives
by: G. N. Mozhokina, et al.
Published: (2021-06-01) -
Metformin hydrochloride laden nanostructured lipid carriers: A promising strategy for skin diseases
by: Reem Y. Mahran, et al.
Published: (2025-01-01) -
Exploring SLT80 nanostructured lipid carriers as a novel delivery system for curcumin: Thermal analysis of experimental and theoretical approach
by: Mahboubeh Pishnamazi, et al.
Published: (2025-06-01) -
Clinical Efficacy and Safety of Clofazimine in Treatment Regimens for Drug Resistant Tuberculosis (Meta-Analysis)
by: A. I. Gayda, et al.
Published: (2024-05-01)